OTCMKTS:CUBTD Curative Biotechnology (CUBTD) Stock Price, News & Analysis $1.10 0.00 (0.00%) As of 07/21/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesSEC FilingsBuy This Stock About Curative Biotechnology Stock (OTCMKTS:CUBTD) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Curative Biotechnology alerts:Sign Up Key Stats Today's Range$1.10▼$1.1050-Day Range$1.10▼$1.1052-Week Range$0.03▼$2.24VolumeN/AAverage Volume2,679 shsMarket Capitalization$7.50 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Curative Biotechnology, Inc., a development-stage biomedical company, focuses on novel treatments for rare diseases. The company focuses on therapies with potentially accelerated development paths as a result of the disease, the nature of the therapeutic itself, or the stage of clinical development. Its pipeline candidates include CURB906, an antibody-drug conjugate for targeting CD56 positive brain tumors; and IMT504, a novel immune therapy to treat rabies. The company has an agreement with Mid-Atlantic BioTherapeutics, Inc. to develop the COVID-19 vaccine. Curative Biotechnology, Inc. was founded in 1995 and is based in Boca Raton, Florida. Read More Receive CUBTD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Curative Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CUBTD Stock News HeadlinesCurative Biotechnology Announces U.S. Patent Allowance Strengthening Core Ophthalmology PlatformJuly 17, 2026 | markets.businessinsider.comCurative Biotechnology Advances Translational Ophthalmology Program Through PennVet Research AgreementMay 7, 2026 | tmcnet.comGrab Your First Trade Playbook (link expires)"Your First Trade Playbook" - normally $29.97 - is free to download today. It walks you through every step, from which account to open to which order button to avoid, so you can be ready for your first options trade in a single sitting. The download link expires soon, and the playbook returns to full price once it does.July 22 at 1:00 AM | Profits Run (Ad)Curative Biotechnology, Inc.: Curative Biotechnology Engages Sterling Pharmaceutical Services to Manufacture Clinical Supply of Metformin Topical Ophthalmic TherapyApril 21, 2026 | finanznachrichten.deCurative Biotechnology Engages Sterling Pharmaceutical Services to Manufacture Clinical Supply of Metformin Topical Ophthalmic TherapyApril 16, 2026 | markets.businessinsider.comCurative Biotechnology, Inc.?: Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB UplistingMarch 24, 2026 | finanznachrichten.deCurative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB UplistingMarch 23, 2026 | globenewswire.comCurative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB UplistingMarch 23, 2026 | markets.businessinsider.comSee More Headlines CUBTD Stock Analysis - Frequently Asked Questions How have CUBTD shares performed this year? Curative Biotechnology's stock was trading at $0.81 at the beginning of the year. Since then, CUBTD shares have increased by 35.8% and is now trading at $1.10. When did Curative Biotechnology's stock split? Curative Biotechnology's stock reverse split before market open on Monday, March 30th 2026.The 1-150 reverse split was announced on Monday, March 30th 2026. The number of shares owned by shareholders was adjusted after the closing bell on Monday, March 30th 2026. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split. How do I buy shares of Curative Biotechnology? Shares of CUBTD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Curative Biotechnology own? Based on aggregate information from My MarketBeat watchlists, some other companies that Curative Biotechnology investors own include Ayala Pharmaceuticals (ADXS), Invesco S&P Global Water Index ETF (CGW), Surge Battery Metals (NILIF), Pressure BioSciences (PBIO) and ACRO (TACI). Company Calendar Today7/22/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED - BIOMED/GENE Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:CUBTD Previous SymbolOTCMKTS:CTYX CIK1400271 Webcurativebiotech.com Phone(561) 418-7725Fax866-900-1002Employees4Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares6,820,000Free FloatN/AMarket Cap$7.50 million OptionableNot Optionable Beta1.31 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (OTCMKTS:CUBTD) was last updated on 7/22/2026 by MarketBeat.com Staff. From Our PartnersTSM just handed Trump's secretive AI project $100 billionTaiwan Semiconductor just committed another $100 billion to U.S. chip manufacturing - on top of $165 billion a...InvestorPlace | SponsoredAmerica’s answer to universal basic incomeRobert Kiyosaki, author of Rich Dad Poor Dad, is highlighting an income strategy he calls the Patriot Income P...Freedom Financial | SponsoredThe Starlink of EnergyA portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...Monument Traders Alliance | SponsoredBlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredElon is about to dominate the biggest arms race in tech historyMicrosoft, Amazon, Alphabet, and Meta have collectively poured nearly $700 billion into AI infrastructure in 2...The Oxford Club | SponsoredThis could help save your retirementMurray Stahl is a Wall Street money manager who put more than half of his $9 billion firm into a single stock ...Stansberry Research | SponsoredA Secret Plan to End Trump in November?A White House insider with close ties to the Trump family is speaking out about what he calls the biggest poli...Paradigm Press | SponsoredIt all happens tonight.Tonight, trader Sean Allison is hosting a live session to walk through his Zero-Dollar Trade Advantage strateg...Trade Thirsty | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Curative Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Curative Biotechnology With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
